Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 24, 2024 06:32 ET | Source: Research and Markets

Global Systemic Aspergillosis and Systemic Candidiasis Research Report 2024-2030 Featuring Sanofi, Cipla, Pfizer, GSK, Novartis, Bayer, Merck, F. Hoffmann-La Roche, Abbott, Gilead Sciences

Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By...
March 28, 2024 08:29 ET | Source: Research and Markets

Global Tinea Pedis Treatment Market Projected to Reach USD 2.9 Billion by 2034, Fueled by Advancements in Treatment Options and Rising Prevalence

Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Tinea Pedis Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global tinea pedis treatment market size was...
January 31, 2024 08:19 ET | Source: Research and Markets

Global Caspofungin Market Projected to Hit USD 590.5 Million by 2034, Asia Pacific Region to Witness Highest Growth Rate

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Caspofungin Market" report has been added to ResearchAndMarkets.com's offering. New insights into the global caspofungin market have been...
April 04, 2023 06:59 ET | Source: Research and Markets

Antifungals Global Market Report 2023: Major Players Include Pfizer, Novartis, Merck & Co and GlaxoSmithKline

Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Antifungals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
May 31, 2021 08:23 ET | Source: Research and Markets

US Onychomycosis Market Size, Trends & Forecasts 2021-2025 Featuring Key Players - Bausch Health Companies, Pfizer, Novartis and Johnson & Johnson

Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "The US Onychomycosis Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering. This report...